15 de April de 2021

ANVISA opens a Public Consultation to improve the reliance on foreign regulatory authorities’ opinions

ANVISA’s Board of Directors opened a Public Consultation (“PC 1,039/2021”), available to contributions between 04/15/2021 and 06/15/2021, to discuss a proposed regulation to establish criteria for ANVISA to rely on the analysis carried out by equivalent foreign regulatory authorities for the purposes of marketing approval of products, optimizing the current procedures.

The optimized analysis consists of a procedure that uses a regulatory document issued by an equivalent foreign regulatory authority to streamline the efficiency of Anvisa’s assessment, avoiding duplication of efforts.

The proposal establishes that the equivalent foreign regulatory authorities must have the same standard of health protection and must adopt international standards and guidelines similar to those adopted by ANVISA, including good regulatory practices.

In addition, authorities that are part of a cooperation program or association integrated by ANVISA may be considered equivalent depending on the category of the product or process. In this case, the foreign regulatory authority would be considered equivalent by a decision to be rendered by ANVISA’s Board of Directors and the updated list of the equivalent authorities would be available on ANVISA's website.

The main goals of the proposal are:

(i) increase product availability through predictability and legal certainty to companies,

(ii) savings in time and financial resources and,

(iii) more strategic use of ANVISA’s resources.

Last but not least, the proposal also presents provisions to stress ANVISA’s autonomy despite the reliance within the optimized procedure.

For more information, please do not hesitate to contact our team via email: regulatorio@kasznarleonardos.com.

Back

Last related news

1 de July de 2026

INPI Ordinance No. 80/2026 and Second Medical Use Patents

INPI Ordinance No. 80/2026, published on June 30, 2026, in the Official Gazette No. 2895, revised Chapter 9 of the Guidelines for Examination … INPI Ordinance No. 80/2026 and Second Medical Use Patents

1 de July de 2026

Joint Judiciary Ordinance Creates Permanent Industrial Property Committee and Strengthens Cooperation Between State and Federal Courts

Joint FOJURJ Ordinance No. 4/2026 was recently published, creating the Permanent Industrial Property Committee within the Judiciary Forum of the State of … Joint Judiciary Ordinance Creates Permanent Industrial Property Committee and Strengthens Cooperation Between State and Federal Courts

30 de June de 2026

New Cycle for Fast-track Examination Requests, Including PPH, Opens in Brazil for Telecommunication Cases

By means of Ordinance 05/2026, published on June 30, 2026, the BPTO has announced that a new cycle for fast-track examination routes, … New Cycle for Fast-track Examination Requests, Including PPH, Opens in Brazil for Telecommunication Cases

Newsletter

ANVISA opens a Public Consultation to improve the reliance on foreign regulatory authorities’ opinions

Last related news

INPI Ordinance No. 80/2026 and Second Medical Use Patents

Joint Judiciary Ordinance Creates Permanent Industrial Property Committee and Strengthens Cooperation Between State and Federal Courts

New Cycle for Fast-track Examination Requests, Including PPH, Opens in Brazil for Telecommunication Cases